炸裂！预增28倍

Core Viewpoint - XianDa Co., Ltd. is expected to see a significant increase in net profit for the first half of 2025, with projections indicating a year-on-year growth of 2443.43% to 2834.73% [2][5]. Summary by Sections XianDa Co., Ltd. Performance - XianDa Co., Ltd. anticipates achieving a net profit attributable to shareholders of between 130 million to 150 million yuan for the first half of 2025, marking a substantial increase compared to the previous year [5]. - The company also expects a net profit excluding non-recurring gains and losses to be between 125 million to 145 million yuan, reflecting an extraordinary growth of 15239.01% to 17667.08% year-on-year [5]. - The significant profit increase is attributed to the rising market price of its main product, Acetochlor, which has boosted the company's gross profit margin [6]. - The launch of a new product, Pyrazole Quinclorac, and ongoing market promotion efforts have contributed additional growth to the company's gross profit [6]. - Continuous cost control measures and improved operational efficiency have further supported the company's performance [6]. Market Context - As of July 9, several A-share listed companies released their performance forecasts for the first half of 2025, with 13 companies expecting a net profit increase of over 100%, while 9 companies forecasted a decline [2][8]. - Jin'an Guoji is projected to experience a net profit decline of 78.56% to 67.83% for the same period, with a net profit attributable to shareholders estimated between 15 million to 22.5 million yuan [8][9]. - The decline in Jin'an Guoji's profits is primarily due to the absence of significant investment gains that were realized in the previous year, as well as asset impairments from the sale of equity stakes [9].